Skip to main content

Children with vesicoureteric reflux have joint hypermobility and occasional tenascin XB sequence variants.

Publication ,  Journal Article
Tokhmafshan, F; El Andalousi, J; Murugapoopathy, V; Fillion, M-L; Campillo, S; Capolicchio, J-P; Jednak, R; El Sherbiny, M; Turpin, S; Gupta, IR ...
Published in: Can Urol Assoc J
April 2020

INTRODUCTION: To consider alternative mechanisms that give rise to a refluxing ureterovesical junction (UVJ), we hypothesized that children with a common heritable urinary tract defect, vesicoureteric reflux (VUR), may have a defect in the extracellular matrix composition of the UVJ and other tissues that would be revealed by assessment of the peripheral joints. Hypermobile joints can arise from defects in the extracellular matrix within the joint capsule that affect proteins, including tenascin XB (TNXB). METHODS: We performed an observational study of children with familial and non-familial VUR to determine the prevalence of joint hypermobility, renal scarring, and DNA sequence variants in TNXB. RESULTS: Most children (27/44) exhibited joint hypermobility using the Beighton scoring system. This included 15/26 girls (57.7%) and 12/18 boys (66.7%), which is a significantly higher prevalence for both sexes when compared to population controls (p<0.005). We found no association between joint hypermobility and renal scarring. Seven of 49 children harbored rare pathogenic sequence variants in TNXB, and two also exhibited joint hypermobility. No sequence variants in TNXB were identified in 25/27 children with VUR and joint hypermobility. Due to the observational design of the study, there was missing data for joint hypermobility scores in six children and for dimercaptosuccinic acid (DMSA) scans in 17 children. CONCLUSIONS: We observed a high prevalence of VUR and joint hypermobility in children followed within a tertiary care pediatric urology clinic. While mutations in TNXB have been reported in families with VUR and joint hypermobility, we identified only two children with these phenotypes and pathogenic variants in TNXB. We, therefore, speculate that VUR and joint hypermobility may be due to mutations in other extracellular matrix genes.

Duke Scholars

Published In

Can Urol Assoc J

DOI

ISSN

1911-6470

Publication Date

April 2020

Volume

14

Issue

4

Start / End Page

E128 / E136

Location

Canada

Related Subject Headings

  • Urology & Nephrology
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tokhmafshan, F., El Andalousi, J., Murugapoopathy, V., Fillion, M.-L., Campillo, S., Capolicchio, J.-P., … Gupta, I. R. (2020). Children with vesicoureteric reflux have joint hypermobility and occasional tenascin XB sequence variants. Can Urol Assoc J, 14(4), E128–E136. https://doi.org/10.5489/cuaj.6068
Tokhmafshan, Fatima, Jasmine El Andalousi, Vasikar Murugapoopathy, Marie-Lyne Fillion, Sarah Campillo, John-Paul Capolicchio, Roman Jednak, et al. “Children with vesicoureteric reflux have joint hypermobility and occasional tenascin XB sequence variants.Can Urol Assoc J 14, no. 4 (April 2020): E128–36. https://doi.org/10.5489/cuaj.6068.
Tokhmafshan F, El Andalousi J, Murugapoopathy V, Fillion M-L, Campillo S, Capolicchio J-P, et al. Children with vesicoureteric reflux have joint hypermobility and occasional tenascin XB sequence variants. Can Urol Assoc J. 2020 Apr;14(4):E128–36.
Tokhmafshan, Fatima, et al. “Children with vesicoureteric reflux have joint hypermobility and occasional tenascin XB sequence variants.Can Urol Assoc J, vol. 14, no. 4, Apr. 2020, pp. E128–36. Pubmed, doi:10.5489/cuaj.6068.
Tokhmafshan F, El Andalousi J, Murugapoopathy V, Fillion M-L, Campillo S, Capolicchio J-P, Jednak R, El Sherbiny M, Turpin S, Schalkwijk J, Matsumoto K-I, Brophy PD, Gbadegesin RA, Gupta IR. Children with vesicoureteric reflux have joint hypermobility and occasional tenascin XB sequence variants. Can Urol Assoc J. 2020 Apr;14(4):E128–E136.

Published In

Can Urol Assoc J

DOI

ISSN

1911-6470

Publication Date

April 2020

Volume

14

Issue

4

Start / End Page

E128 / E136

Location

Canada

Related Subject Headings

  • Urology & Nephrology
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences